SCL Science Inc.

SCL Science Inc. specializes in chitosan-based haemostatic agents, specifically non-bioabsorbable pads designed for professional medical use. These devices are formulated to control bleeding by accelerating clotting in surgical and trauma settings, particularly for arterial and venous bleeding. The primary focus is on haemostatic solutions that remain in place after use.

SCL Science Inc. is based in the United States, where its haemostatic pads are developed and distributed. The company’s operations, including research, manufacturing, and distribution, are centered within the country.

SCL Science Inc.’s haemostatic pads are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and transparency of medical devices in the United States, allowing healthcare providers and regulators to identify and track specific products.

SCL Science Inc.’s chitosan haemostatic pads are classified as Class II (U) devices under FDA regulations. This classification is based on their intended use—controlling bleeding in surgical and trauma settings—where they pose moderate risk. Class II devices require special controls beyond general controls to ensure safety and effectiveness, as determined by the FDA.